Find clinical trials for Non-Small-Cell Lung Cancer in Birmingham, AL
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Non-Small-Cell Lung Cancer trials near Birmingham, AL, USA:
This study is being done to determine the efficacy and safety of cofetuzumab pelidotin in the PTK7-expressing, recurrent non-small ...
Phase 1
Birmingham, Alabama, United States and 25 other locations
The purpose of this study is to understand if PF-08046054 alone works well compared to standard-of-care docetaxel alone in participants with non...
Phase 3
Birmingham, Alabama, United States and 85 other locations
Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. Non-small cell...
Phase 3
Birmingham, Alabama, United States and 314 other locations
study population comprises adults with either advanced/metastatic non-small cell lung cancer (NSCLC) wit...
Phase 1, Phase 2
Birmingham, Alabama, United States and 28 other locations
This study will evaluate REGN5093 for the treatment of Non-Small Cell Lung Cancer (NSCLC) with MET alter...
Phase 1, Phase 2
Birmingham, Alabama, United States and 32 other locations
The purpose of this study is to assess the objective response rate (ORR) of immunotherapy-based combination therapy and to assess the safety and tole...
Phase 2
Birmingham, Alabama, United States and 50 other locations
adaptive radiotherapy with concomitant chemotherapy for stage III non-small cell lung cancer (NSCLC) wil...
Birmingham, Alabama, United States
Researchers want to learn if the study medicines MK-1084 and subcutaneous (SC) pembrolizumab can be used to treat non-small cell...
Phase 3
Birmingham, Alabama, United States of America and 30 other locations
and platinum-based chemotherapy for patients with advanced non-small cell lung cancer that has spread to...
Phase 3
Birmingham, Alabama, United States of America and 90 other locations
This study is about a medicine called TAK-788, also known as mobocertinib, given to adults with non-small cell lung...
Phase 1, Phase 2
Birmingham, Alabama, United States and 61 other locations
Clinical trials
Research sites
Resources
Legal